NUMD Nu-Med Plus Inc.

Nu-Med Plus, Inc. engages in the development, manufacture, and marketing of technologies utilizing nitric oxide in the medical device field. It includes nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company was founded on October 19, 2011 and is headquartered in Salt Lake City, UT.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.03    OTCQB
As of 01/25/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  09/25/2014
Outstanding shares:  79,348,469
Average volume:  20,865
Market cap:   $2,459,803
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -10.14
PB ratio:   3.44
PS ratio:   262.13
Return on equity:   1,729.71%
Net income %:   -12,905.95%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy